GRAMMER ELIZABETH A 4

What Happened
Elizabeth A. Grammer, a director of Sagimet Biosciences, was granted a derivative award on June 12, 2026 covering 39,567 shares (reported as $0.00 per share). The Form 4 lists this as an award/grant (transaction code A); the reported dollar value for the transaction on the filing is $0.

Key Details

• Transaction date: 2026-06-12; Form 4 filed 2026-06-15 (appears timely).
• Transaction type: Award/Grant of a derivative security (listed as 39,567 shares at $0.00).
• Vesting/exercise terms: The shares underlying this option vest and become exercisable in twelve (12) equal monthly installments following June 12, 2026, subject to continued service.
• Amount owned following the transaction: Not specified in the provided filing.
• Transaction code: A (award/grant). No 10b5-1, tax withholding, or sale noted in this filing.

Context
This is a compensation-related grant to a board member rather than an open-market buy or sale. Because the award vests monthly over a year and becomes exercisable over time, it does not represent immediately exercisable or liquid stock. Such grants are common as director compensation and do not, by themselves, indicate a buy or sell signal.